Sign up to save your podcasts
Or
Share Personalized medicine & survival prediction | Robert Nagourney
Share to email
Share to Facebook
Share to X
Share to email
Share to Facebook
Share to X
Or
Personalized medicine & survival prediction | Robert Nagourney
Robert Nagourney MD, is Medical and Laboratory Director of The Nagourney Cancer Institute in Long Beach, California, Associate Clinical Professor, at University of California Irvine and founder and CEO of Metabolomycs, Inc. He is board certified in internal medicine, medical oncology, and hematology.
Favorite metabolite
Glutamine
Learn more about his work:
Nagourney Cancer Institute
Metabolomycs
TEDx talk
Paper we discussed in this episode
Ovarian cancer | Platinum resistance in gynecologic malignancies: Response, disease free and overall survival are predicted by biochemical signature: A metabolomic analysis
Pancreatic cancer | Diagnostic and Prognostic Performance of Metabolic Signatures in Pancreatic Ductal Adenocarcinoma: The Clinical Application of Quantitative NextGen Mass Spectrometry
Sign up for The Metabolomist mailing list to be the first to hear about the latest episodes and news around metabolomics at https://themetabolomist.com
Alices first book
The STORY principle - A guide to the biological interpretation of metabolomics
Also featuring some of the Metabolomists from Season 1
Available on Amazon and the biocrates webshop
View all episodes
By biocrates life sciencesRobert Nagourney MD, is Medical and Laboratory Director of The Nagourney Cancer Institute in Long Beach, California, Associate Clinical Professor, at University of California Irvine and founder and CEO of Metabolomycs, Inc. He is board certified in internal medicine, medical oncology, and hematology.
Favorite metabolite
Glutamine
Learn more about his work:
Nagourney Cancer Institute
Metabolomycs
TEDx talk
Paper we discussed in this episode
Ovarian cancer | Platinum resistance in gynecologic malignancies: Response, disease free and overall survival are predicted by biochemical signature: A metabolomic analysis
Pancreatic cancer | Diagnostic and Prognostic Performance of Metabolic Signatures in Pancreatic Ductal Adenocarcinoma: The Clinical Application of Quantitative NextGen Mass Spectrometry
Sign up for The Metabolomist mailing list to be the first to hear about the latest episodes and news around metabolomics at https://themetabolomist.com
Alices first book
The STORY principle - A guide to the biological interpretation of metabolomics
Also featuring some of the Metabolomists from Season 1
Available on Amazon and the biocrates webshop